Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07385313 · ClinicalTrials.gov registry record · Phase 4
Combined OFM and Vacuum-assisted Therapy for Expedited Regeneration Over Structures
A Phase 4 study, sponsored by Aroa Biosurgery Limited.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT07385313 is a Phase 4 study that is actively recruiting participants, run by Aroa Biosurgery Limited. The registered enrollment target is 30 participants.
The verdict
NCT07385313, a Phase 4 study, is actively recruiting participants, sponsored by Aroa Biosurgery Limited.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
Demonstrate faster tissue coverage of exposed structures using OFM in combination with negative pressure wound therapy (NPWT), versus NPWT alone
Interventions
- DEVICE Myriad™ applied in conjunction with NPWT
- DEVICE NPWT Alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-03-31 |
| Est. Completion | 2027-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07385313
The ClinicalTrials.gov registry entry for NCT07385313 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aroa Biosurgery Limited, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Myriad™ applied in conjunction with NPWT is the first listed.
NCT07385313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07385313 about?
NCT07385313 is a clinical study titled "Combined OFM and Vacuum-assisted Therapy for Expedited Regeneration Over Structures". Demonstrate faster tissue coverage of exposed structures using OFM in combination with negative pressure wound therapy (NPWT), versus NPWT alone
What is the current status of trial NCT07385313?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2026-03-31. Estimated completion is 2027-04.
What interventions are being tested in trial NCT07385313?
The interventions under investigation include: Myriad™ applied in conjunction with NPWT (DEVICE), NPWT Alone (DEVICE).
Who is sponsoring clinical trial NCT07385313?
This trial is sponsored by Aroa Biosurgery Limited, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.